HM15421/GC1134A

· GC Biopharma Corp

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for HM15421/GC1134A, covering 2025-11-04 to 2025-11-04. Get the full timeline:

Most recent: Clinical Trial Update: A proof-of Concept Study to Assess Safety and Tolerability of HM15421/GC1134A in Patients With Fabry Disease [Phase 1, Phase 2]

See pricing